A two-part phase I study of ALB 127158A in healthy volunteers and patients with obesity.
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2011
At a glance
- Drugs ALB 127158A (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Jun 2011 Topline results have been reported in a AMRI media release.
- 01 Jun 2011 Status changed from recruiting to completed.
- 22 Jul 2010 This trial is expected to be complete in the first quarter of 2011, according to an AMRI media release.